Serrated colon polyps as precursors to colorectal cancer

Seth Sweetser, Thomas Christopher Smyrk, Frank A Sinicrope

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Identification of the serrated neoplasia pathway has improved our understanding of the pathogenesis of colorectal cancer (CRC). Insights include an increased recognition of the malignant potential of different types of serrated polyps such as sessile and traditional serrated adenomas. Sessile serrated adenomas share molecular features with colon tumors that have microsatellite instability and a methylator phenotype, indicating that these lesions are precursors that progress via the serrated neoplasia pathway. These data have important implications for clinical practice and CRC prevention, because hyperplastic polyps were previously regarded as having no malignant potential. There is also evidence that the serrated pathway contributes to interval or missed cancers. Endoscopic detection of serrated polyps is a challenge because they are often inconspicuous with indistinct margins and are frequently covered by adherent mucus. It is important for gastroenterologists to recognize the subtle endoscopic features of serrated polyps to facilitate their detection and removal, and thereby ensure a high-quality colonoscopic examination. Recognition of the role of serrated polyps in colon carcinogenesis has led to the inclusion of these lesions in postpolypectomy surveillance guidelines. However, an enhanced effort is needed to identify and completely remove serrated adenomas, with the goal of increasing the effectiveness of colonoscopy to reduce CRC incidence.

Original languageEnglish (US)
Pages (from-to)760-767
Number of pages8
JournalClinical Gastroenterology and Hepatology
Volume11
Issue number7
DOIs
StatePublished - Jul 2013

Fingerprint

Polyps
Colorectal Neoplasms
Colon
Adenoma
Neoplasms
Microsatellite Instability
Colonoscopy
Mucus
Carcinogenesis
Guidelines
Phenotype
Incidence

Keywords

  • Colon Cancer
  • Serrated Polyposis Syndrome
  • Serrated Polyps
  • Sessile Serrated Adenomas

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Serrated colon polyps as precursors to colorectal cancer. / Sweetser, Seth; Smyrk, Thomas Christopher; Sinicrope, Frank A.

In: Clinical Gastroenterology and Hepatology, Vol. 11, No. 7, 07.2013, p. 760-767.

Research output: Contribution to journalArticle

Sweetser, Seth ; Smyrk, Thomas Christopher ; Sinicrope, Frank A. / Serrated colon polyps as precursors to colorectal cancer. In: Clinical Gastroenterology and Hepatology. 2013 ; Vol. 11, No. 7. pp. 760-767.
@article{984874f6faf040bfaa995b827f48d331,
title = "Serrated colon polyps as precursors to colorectal cancer",
abstract = "Identification of the serrated neoplasia pathway has improved our understanding of the pathogenesis of colorectal cancer (CRC). Insights include an increased recognition of the malignant potential of different types of serrated polyps such as sessile and traditional serrated adenomas. Sessile serrated adenomas share molecular features with colon tumors that have microsatellite instability and a methylator phenotype, indicating that these lesions are precursors that progress via the serrated neoplasia pathway. These data have important implications for clinical practice and CRC prevention, because hyperplastic polyps were previously regarded as having no malignant potential. There is also evidence that the serrated pathway contributes to interval or missed cancers. Endoscopic detection of serrated polyps is a challenge because they are often inconspicuous with indistinct margins and are frequently covered by adherent mucus. It is important for gastroenterologists to recognize the subtle endoscopic features of serrated polyps to facilitate their detection and removal, and thereby ensure a high-quality colonoscopic examination. Recognition of the role of serrated polyps in colon carcinogenesis has led to the inclusion of these lesions in postpolypectomy surveillance guidelines. However, an enhanced effort is needed to identify and completely remove serrated adenomas, with the goal of increasing the effectiveness of colonoscopy to reduce CRC incidence.",
keywords = "Colon Cancer, Serrated Polyposis Syndrome, Serrated Polyps, Sessile Serrated Adenomas",
author = "Seth Sweetser and Smyrk, {Thomas Christopher} and Sinicrope, {Frank A}",
year = "2013",
month = "7",
doi = "10.1016/j.cgh.2012.12.004",
language = "English (US)",
volume = "11",
pages = "760--767",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "7",

}

TY - JOUR

T1 - Serrated colon polyps as precursors to colorectal cancer

AU - Sweetser, Seth

AU - Smyrk, Thomas Christopher

AU - Sinicrope, Frank A

PY - 2013/7

Y1 - 2013/7

N2 - Identification of the serrated neoplasia pathway has improved our understanding of the pathogenesis of colorectal cancer (CRC). Insights include an increased recognition of the malignant potential of different types of serrated polyps such as sessile and traditional serrated adenomas. Sessile serrated adenomas share molecular features with colon tumors that have microsatellite instability and a methylator phenotype, indicating that these lesions are precursors that progress via the serrated neoplasia pathway. These data have important implications for clinical practice and CRC prevention, because hyperplastic polyps were previously regarded as having no malignant potential. There is also evidence that the serrated pathway contributes to interval or missed cancers. Endoscopic detection of serrated polyps is a challenge because they are often inconspicuous with indistinct margins and are frequently covered by adherent mucus. It is important for gastroenterologists to recognize the subtle endoscopic features of serrated polyps to facilitate their detection and removal, and thereby ensure a high-quality colonoscopic examination. Recognition of the role of serrated polyps in colon carcinogenesis has led to the inclusion of these lesions in postpolypectomy surveillance guidelines. However, an enhanced effort is needed to identify and completely remove serrated adenomas, with the goal of increasing the effectiveness of colonoscopy to reduce CRC incidence.

AB - Identification of the serrated neoplasia pathway has improved our understanding of the pathogenesis of colorectal cancer (CRC). Insights include an increased recognition of the malignant potential of different types of serrated polyps such as sessile and traditional serrated adenomas. Sessile serrated adenomas share molecular features with colon tumors that have microsatellite instability and a methylator phenotype, indicating that these lesions are precursors that progress via the serrated neoplasia pathway. These data have important implications for clinical practice and CRC prevention, because hyperplastic polyps were previously regarded as having no malignant potential. There is also evidence that the serrated pathway contributes to interval or missed cancers. Endoscopic detection of serrated polyps is a challenge because they are often inconspicuous with indistinct margins and are frequently covered by adherent mucus. It is important for gastroenterologists to recognize the subtle endoscopic features of serrated polyps to facilitate their detection and removal, and thereby ensure a high-quality colonoscopic examination. Recognition of the role of serrated polyps in colon carcinogenesis has led to the inclusion of these lesions in postpolypectomy surveillance guidelines. However, an enhanced effort is needed to identify and completely remove serrated adenomas, with the goal of increasing the effectiveness of colonoscopy to reduce CRC incidence.

KW - Colon Cancer

KW - Serrated Polyposis Syndrome

KW - Serrated Polyps

KW - Sessile Serrated Adenomas

UR - http://www.scopus.com/inward/record.url?scp=84879221566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879221566&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2012.12.004

DO - 10.1016/j.cgh.2012.12.004

M3 - Article

VL - 11

SP - 760

EP - 767

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 7

ER -